Balanced news tone
News Sentiment
8037 sentiment intelligence
China Biotech Services Holdings Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
95/100 classification confidence.
directly relevant articles
high-authority source matches
+43.5% over one week, +29.8% over four weeks, trend inactive, and near fair-value range.
Hang Seng jumps as healthcare and biotech stocks rally despite weak China GDP data
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Hang Seng jumps as healthcare and biotech stocks rally despite weak China GDP data
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 15 Jul 2026 03:35
- Source
- Invezz
Hong Kong draws royalties giant as mainland China biotech licensing heats up
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- South China Morning Post
Breakingviews - Pentagon casts dark cloud over China biotech
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Reuters
Global drugmakers eye more China biotech deals after record year
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- KrASIA
Ribo, Diagens tally 2 Hong Kong biotech, medtech IPOs in Q1 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Apr 2026 07:00
- Source
- BioWorld News
China healthcare stocks shine in Hong Kong amid Middle East turmoil
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Apr 2026 07:00
- Source
- South China Morning Post
Hong Kong attracts wave of biotech IPO filings amid AI drug research boom
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Mar 2026 07:00
- Source
- South China Morning Post
China investors energise Hong Kong biotech stocks. Is foreign money missing out?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Mar 2026 07:00
- Source
- South China Morning Post
China leads US in biotech clinical trials
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Mar 2026 08:00
- Source
- BioXconomy
MoonLake revives FDA push; Biotech trio to debut in Hong Kong
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jan 2026 08:00
- Source
- Endpoints News
China’s rising biotech clout on show in flurry of billion-dollar licensing deals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Dec 2025 08:00
- Source
- South China Morning Post
73 Chinese biotech, med-tech companies file for HK IPOs in 2025
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Dec 2025 08:00
- Source
- BioWorld News
China’s biotech boom is being driven by a dazzling market rebound
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Nov 2025 08:00
- Source
- STAT
China Biotech’s DeepSeek Moment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Sep 2025 07:00
- Source
- allianzgi.com
TransThera’s 4,500% surge sparks bubble fears in China healthcare stocks
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Sep 2025 07:00
- Source
- South China Morning Post
Supporting a Hong Kong biotech IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Aug 2025 07:00
- Source
- Macquarie
Wuxi AppTec joins funding rush as appetite grows for China’s biotech
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Jul 2025 07:00
- Source
- South China Morning Post
Technical Analysis of China Biotech Services Holdings Limited (HKEX:8037)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Feb 2018 07:36
- Source
- TradingView